Cargando…
Comparison of peptide–major histocompatibility complex tetramers and dextramers for the identification of antigen-specific T cells
Fluorochrome-conjugated peptide–major histocompatibility complex (pMHC) multimers are widely used for flow cytometric visualization of antigen-specific T cells. The most common multimers, streptavidin–biotin-based ‘tetramers’, can be manufactured readily in the laboratory. Unfortunately, there are l...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Science Inc
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089154/ https://www.ncbi.nlm.nih.gov/pubmed/24673376 http://dx.doi.org/10.1111/cei.12339 |
_version_ | 1782325082553581568 |
---|---|
author | Dolton, G Lissina, A Skowera, A Ladell, K Tungatt, K Jones, E Kronenberg-Versteeg, D Akpovwa, H Pentier, J M Holland, C J Godkin, A J Cole, D K Neller, M A Miles, J J Price, D A Peakman, M Sewell, A K |
author_facet | Dolton, G Lissina, A Skowera, A Ladell, K Tungatt, K Jones, E Kronenberg-Versteeg, D Akpovwa, H Pentier, J M Holland, C J Godkin, A J Cole, D K Neller, M A Miles, J J Price, D A Peakman, M Sewell, A K |
author_sort | Dolton, G |
collection | PubMed |
description | Fluorochrome-conjugated peptide–major histocompatibility complex (pMHC) multimers are widely used for flow cytometric visualization of antigen-specific T cells. The most common multimers, streptavidin–biotin-based ‘tetramers’, can be manufactured readily in the laboratory. Unfortunately, there are large differences between the threshold of T cell receptor (TCR) affinity required to capture pMHC tetramers from solution and that which is required for T cell activation. This disparity means that tetramers sometimes fail to stain antigen-specific T cells within a sample, an issue that is particularly problematic when staining tumour-specific, autoimmune or MHC class II-restricted T cells, which often display TCRs of low affinity for pMHC. Here, we compared optimized staining with tetramers and dextramers (dextran-based multimers), with the latter carrying greater numbers of both pMHC and fluorochrome per molecule. Most notably, we find that: (i) dextramers stain more brightly than tetramers; (ii) dextramers outperform tetramers when TCR–pMHC affinity is low; (iii) dextramers outperform tetramers with pMHC class II reagents where there is an absence of co-receptor stabilization; and (iv) dextramer sensitivity is enhanced further by specific protein kinase inhibition. Dextramers are compatible with current state-of-the-art flow cytometry platforms and will probably find particular utility in the fields of autoimmunity and cancer immunology. |
format | Online Article Text |
id | pubmed-4089154 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Blackwell Science Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-40891542014-12-15 Comparison of peptide–major histocompatibility complex tetramers and dextramers for the identification of antigen-specific T cells Dolton, G Lissina, A Skowera, A Ladell, K Tungatt, K Jones, E Kronenberg-Versteeg, D Akpovwa, H Pentier, J M Holland, C J Godkin, A J Cole, D K Neller, M A Miles, J J Price, D A Peakman, M Sewell, A K Clin Exp Immunol Technology Advance Fluorochrome-conjugated peptide–major histocompatibility complex (pMHC) multimers are widely used for flow cytometric visualization of antigen-specific T cells. The most common multimers, streptavidin–biotin-based ‘tetramers’, can be manufactured readily in the laboratory. Unfortunately, there are large differences between the threshold of T cell receptor (TCR) affinity required to capture pMHC tetramers from solution and that which is required for T cell activation. This disparity means that tetramers sometimes fail to stain antigen-specific T cells within a sample, an issue that is particularly problematic when staining tumour-specific, autoimmune or MHC class II-restricted T cells, which often display TCRs of low affinity for pMHC. Here, we compared optimized staining with tetramers and dextramers (dextran-based multimers), with the latter carrying greater numbers of both pMHC and fluorochrome per molecule. Most notably, we find that: (i) dextramers stain more brightly than tetramers; (ii) dextramers outperform tetramers when TCR–pMHC affinity is low; (iii) dextramers outperform tetramers with pMHC class II reagents where there is an absence of co-receptor stabilization; and (iv) dextramer sensitivity is enhanced further by specific protein kinase inhibition. Dextramers are compatible with current state-of-the-art flow cytometry platforms and will probably find particular utility in the fields of autoimmunity and cancer immunology. Blackwell Science Inc 2014-07 2014-06-09 /pmc/articles/PMC4089154/ /pubmed/24673376 http://dx.doi.org/10.1111/cei.12339 Text en © 2014 The Authors. Clinical & Experimental Immunology published by John Wiley & Sons Ltd on behalf of British Society for Immunology http://creativecommons.org/licenses/by/3.0/ This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Technology Advance Dolton, G Lissina, A Skowera, A Ladell, K Tungatt, K Jones, E Kronenberg-Versteeg, D Akpovwa, H Pentier, J M Holland, C J Godkin, A J Cole, D K Neller, M A Miles, J J Price, D A Peakman, M Sewell, A K Comparison of peptide–major histocompatibility complex tetramers and dextramers for the identification of antigen-specific T cells |
title | Comparison of peptide–major histocompatibility complex tetramers and dextramers for the identification of antigen-specific T cells |
title_full | Comparison of peptide–major histocompatibility complex tetramers and dextramers for the identification of antigen-specific T cells |
title_fullStr | Comparison of peptide–major histocompatibility complex tetramers and dextramers for the identification of antigen-specific T cells |
title_full_unstemmed | Comparison of peptide–major histocompatibility complex tetramers and dextramers for the identification of antigen-specific T cells |
title_short | Comparison of peptide–major histocompatibility complex tetramers and dextramers for the identification of antigen-specific T cells |
title_sort | comparison of peptide–major histocompatibility complex tetramers and dextramers for the identification of antigen-specific t cells |
topic | Technology Advance |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089154/ https://www.ncbi.nlm.nih.gov/pubmed/24673376 http://dx.doi.org/10.1111/cei.12339 |
work_keys_str_mv | AT doltong comparisonofpeptidemajorhistocompatibilitycomplextetramersanddextramersfortheidentificationofantigenspecifictcells AT lissinaa comparisonofpeptidemajorhistocompatibilitycomplextetramersanddextramersfortheidentificationofantigenspecifictcells AT skoweraa comparisonofpeptidemajorhistocompatibilitycomplextetramersanddextramersfortheidentificationofantigenspecifictcells AT ladellk comparisonofpeptidemajorhistocompatibilitycomplextetramersanddextramersfortheidentificationofantigenspecifictcells AT tungattk comparisonofpeptidemajorhistocompatibilitycomplextetramersanddextramersfortheidentificationofantigenspecifictcells AT jonese comparisonofpeptidemajorhistocompatibilitycomplextetramersanddextramersfortheidentificationofantigenspecifictcells AT kronenbergversteegd comparisonofpeptidemajorhistocompatibilitycomplextetramersanddextramersfortheidentificationofantigenspecifictcells AT akpovwah comparisonofpeptidemajorhistocompatibilitycomplextetramersanddextramersfortheidentificationofantigenspecifictcells AT pentierjm comparisonofpeptidemajorhistocompatibilitycomplextetramersanddextramersfortheidentificationofantigenspecifictcells AT hollandcj comparisonofpeptidemajorhistocompatibilitycomplextetramersanddextramersfortheidentificationofantigenspecifictcells AT godkinaj comparisonofpeptidemajorhistocompatibilitycomplextetramersanddextramersfortheidentificationofantigenspecifictcells AT coledk comparisonofpeptidemajorhistocompatibilitycomplextetramersanddextramersfortheidentificationofantigenspecifictcells AT nellerma comparisonofpeptidemajorhistocompatibilitycomplextetramersanddextramersfortheidentificationofantigenspecifictcells AT milesjj comparisonofpeptidemajorhistocompatibilitycomplextetramersanddextramersfortheidentificationofantigenspecifictcells AT priceda comparisonofpeptidemajorhistocompatibilitycomplextetramersanddextramersfortheidentificationofantigenspecifictcells AT peakmanm comparisonofpeptidemajorhistocompatibilitycomplextetramersanddextramersfortheidentificationofantigenspecifictcells AT sewellak comparisonofpeptidemajorhistocompatibilitycomplextetramersanddextramersfortheidentificationofantigenspecifictcells |